Stifel analyst David Grossman raised the firm’s price target on IBM (IBM) to $310 from $290 and keeps a Buy rating on the shares. While fundamentals are stable/positive, there may be difficult to predict upward earnings revisions in the current environment, which creates incremental risk into the earnings report and may suggest that a post-Q2 report is a more opportunistic entry point, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- IBM price target raised to $253 from $233 at Morgan Stanley
- IBM Stock: Balancing Growth Opportunities with Valuation Concerns
- $1.16 Billion Flows into Quantum in Q2 2025 as Big Tech and Investors Up Their Game
- How IBM’s Agentic AI Is Changing the Way Sales Teams Close Deals
- U.S. and Israel Launch $200 Million Quantum-AI Fund to Counter China